Referred to the House Committee on Energy and Commerce.
This bill reauthorizes and funds the program that pays children’s hospitals that operate graduate medical education (GME) programs through fiscal year 2030, including specified annual funding levels. It adds a new condition that hospitals that furnished certain listed surgeries or drugs to individuals under 18 during the prior fiscal year are ineligible for those payments beginning in fiscal year 2026, with limited exceptions (e.g., precocious puberty, certain intersex conditions, emergency care) and a special transitional rule for part of FY2026.
Progressives emphasize harm to trans youth and chilling clinical care
Relative to its intended legislative type, this bill is a well-specified statutory amendment to an existing payment program with clear definitions and funding authorizations, but it lacks procedural and accountability mechanisms needed to implement and enforce the new payment prohibition.
This bill reauthorizes and funds the program that pays children’s hospitals that operate graduate medical education (GME) programs through fiscal year 2030, including specified annual funding levels.
It adds a new condition that hospitals that furnished certain listed surgeries or drugs to individuals under 18 during the prior fiscal year are ineligible for those payments beginning in fiscal year 2026, with limited exceptions (e.g., precocious puberty, certain intersex conditions, emergency care) and a special transitional rule for part of FY2026.
The bill lists many specific procedures (various genital/ chest surgeries and facial feminizing/masculinizing surgeries) and drugs (puberty blockers, gender-affirming hormones) covered by the prohibition, and preserves payments for non-procedural mental or behavioral health treatments for gender dysphoria that do not involve the specified procedures or drugs.
Narrow reauthorization bundled with a highly contentious funding condition reduces prospects in a split or closely divided Congress and invites legal and policy pushback.
Relative to its intended legislative type, this bill is a well-specified statutory amendment to an existing payment program with clear definitions and funding authorizations, but it lacks procedural and accountability mechanisms needed to implement and enforce the new payment prohibition.
Progressives emphasize harm to trans youth and chilling clinical care
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize harm to trans youth and chilling clinical care
Likely to view the bill as a punitive federal restriction on medical care for transgender and gender-diverse youth and as politicizing hospital funding.
They would be concerned the payment prohibition will chill evidence-based care, reduce access, and jeopardize pediatric training programs that serve vulnerable populations.
Mixed reaction: appreciates reauthorization and predictable funding but worries about federal micromanagement of clinical practice and unintended access consequences.
Would want clearer definitions, implementation details, and assessment of impacts on hospital training and pediatric access before full support.
Likely to support the bill as protecting minors and ensuring taxpayer-funded GME payments do not subsidize gender-transition surgeries or hormone treatments for children.
Values the explicit exceptions for precocious puberty and intersex conditions while endorsing the funding reauthorization.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow reauthorization bundled with a highly contentious funding condition reduces prospects in a split or closely divided Congress and invites legal and policy pushback.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize harm to trans youth and chilling clinical care
Narrow reauthorization bundled with a highly contentious funding condition reduces prospects in a split or closely divided Congress and inv…
Relative to its intended legislative type, this bill is a well-specified statutory amendment to an existing payment program with clear definitions and funding authorizations, but it lacks procedural and accountability m…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.